Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
Technology
E-136-2018
Patent ID
E-136-2018-1-CN-04
Country
CN
Application Type
National Stage
Patent Status
Pending
Patent Number
Publication Number
CN109073650A
Application Number
201780011505.X
IC
NCI
Date Filed
Date Issued
Patent PDF